rs879254643
Variant summary
Our verdict is Likely benign. The variant received 0 ACMG points: 2P and 2B. BP7PM2BP4
This summary comes from the ClinGen Evidence Repository: The NM_000527.5(LDLR):c.690C>T (p.Asn230=) variant is classified as Likely Benign for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2, BP4, and BP7 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on January 31, 2025. Variant has 2 Supporting evidence codes towards Benign, enough to classify as Likely benign and only 1 Moderate evidence codes towards Pathogenic, so we are confident in classifying this variant as Likely benign.The supporting evidence is as follows: PM2: This variant is absent from gnomAD (gnomAD v4.1.0). So, PM2 is met. BP4: No REVEL found. Splicing evaluation required.Functional data on splicing not available.A) not on limitsB) does not create GTC) no GT nearbyVariant is not predicted to alter splicing. So, BP4 is met. BP7: Variant is synonymous and meets BP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10585082/MONDO:0007750/013
Frequency
Consequence
NM_000527.5 synonymous
Scores
Clinical Significance
Conservation
Publications
- hypercholesterolemia, familial, 1Inheritance: AD, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen
- homozygous familial hypercholesterolemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LDLR | NM_000527.5 | MANE Select | c.690C>T | p.Asn230Asn | synonymous | Exon 4 of 18 | NP_000518.1 | ||
| LDLR | NM_001195798.2 | c.690C>T | p.Asn230Asn | synonymous | Exon 4 of 18 | NP_001182727.1 | |||
| LDLR | NM_001195799.2 | c.567C>T | p.Asn189Asn | synonymous | Exon 3 of 17 | NP_001182728.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LDLR | ENST00000558518.6 | TSL:1 MANE Select | c.690C>T | p.Asn230Asn | synonymous | Exon 4 of 18 | ENSP00000454071.1 | ||
| LDLR | ENST00000252444.10 | TSL:1 | c.948C>T | p.Asn316Asn | synonymous | Exon 4 of 18 | ENSP00000252444.6 | ||
| LDLR | ENST00000558013.5 | TSL:1 | c.690C>T | p.Asn230Asn | synonymous | Exon 4 of 18 | ENSP00000453346.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 1 Uncertain:1Benign:2
The NM_000527.5(LDLR):c.690C>T (p.Asn230=) variant is classified as Likely Benign for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2, BP4, and BP7 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on January 31, 2025. Variant has 2 Supporting evidence codes towards Benign, enough to classify as Likely benign and only 1 Moderate evidence codes towards Pathogenic, so we are confident in classifying this variant as Likely benign. The supporting evidence is as follows: PM2: This variant is absent from gnomAD (gnomAD v4.1.0). So, PM2 is met. BP4: No REVEL found. Splicing evaluation required. Functional data on splicing not available. A) not on limits B) does not create GT C) no GT nearby Variant is not predicted to alter splicing. So, BP4 is met. BP7: Variant is synonymous and meets BP4.
Familial hypercholesterolemia Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at